Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Torresi

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Plos One|October 24, 2012
Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesBrendon Y Chua, Douglas Johnson, Amabel Tan, et al.
Intervirology|March 27, 2009
Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinomaC-Thomas Bock, Nguyen L Toan, Bernd Koeberlein, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2007
Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirinIrene Boo, Alexandra E Fischer, Doug Johnson, et al.
Journal of Travel Medicine|April 13, 2013
The incidence of HBV and HCV infection in Australian travelers to AsiaDouglas F Johnson, Irani Ratnam, Elizabeth Matchett, et al.
Vaccine|May 6, 2008
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infectionBrendon Y Chua, Emily M Eriksson, Lorena E Brown, et al.
Journal of Hepatology|May 22, 2007
Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesisRuth Chin, Linda Earnest-Silveira, Bernd Koeberlein, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 11, 2012
Impaired dendritic cell maturation in response to pandemic H1N109 influenza virusRuth Chin, Linda Earnest-Silviera, Claire L Gordon, et al.
Virus Research|September 30, 2009
Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virusRuth Chin, Ulrich Nachbur, Linda Earnest-Silveira, et al.
Virology|March 12, 2002
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapyJoseph Torresi, Linda Earnest-Silveira, Georgia Deliyannis, et al.
Clinical Immunology (Orlando, Fla.)|June 6, 2008
Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell responseDuangtawan Thammanichanond, Sarah Moneer, Patricia Yotnda, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Plos One|October 24, 2012
Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesBrendon Y Chua, Douglas Johnson, Amabel Tan, et al.
Intervirology|March 27, 2009
Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinomaC-Thomas Bock, Nguyen L Toan, Bernd Koeberlein, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2007
Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirinIrene Boo, Alexandra E Fischer, Doug Johnson, et al.
Journal of Travel Medicine|April 13, 2013
The incidence of HBV and HCV infection in Australian travelers to AsiaDouglas F Johnson, Irani Ratnam, Elizabeth Matchett, et al.
Vaccine|May 6, 2008
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infectionBrendon Y Chua, Emily M Eriksson, Lorena E Brown, et al.
Journal of Hepatology|May 22, 2007
Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesisRuth Chin, Linda Earnest-Silveira, Bernd Koeberlein, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 11, 2012
Impaired dendritic cell maturation in response to pandemic H1N109 influenza virusRuth Chin, Linda Earnest-Silviera, Claire L Gordon, et al.
Virus Research|September 30, 2009
Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virusRuth Chin, Ulrich Nachbur, Linda Earnest-Silveira, et al.
Virology|March 12, 2002
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapyJoseph Torresi, Linda Earnest-Silveira, Georgia Deliyannis, et al.
Clinical Immunology (Orlando, Fla.)|June 6, 2008
Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell responseDuangtawan Thammanichanond, Sarah Moneer, Patricia Yotnda, et al.
Pageof 13